Introduction

Introduction

Recent years have seen a surge in interest from the pharmaceutical industry in the neuromuscular field. Yet it is still a field in which locating the PIs and the sites with the expertise to run trials and the patient cohorts to enrol into them can remain a challenge.

TREAT-NMD brings together the key players in the neuromuscular field and is a natural partner for biotech and pharmaceutical companies developing new therapeutics for neuromuscular conditions. Our tools and services and the unparalleled depth of expertise covered by our global network can support, simplify and accelerate the trial and approval process.

We encourage you to browse through the following pages to familiarize yourselves with our range of services, and then get in touch to discuss your specific requirements. We can provide advice and support from the very earliest stages of clinical development and trial planning.

 
12 Apr 2017